Compare
Astrotech Corp vs Seer, Inc. vs Precipio, Inc. vs Bionano Genomics, Inc.
| Latest fiscal year | Astrotech Corp ASTC | Seer, Inc. SEER | Precipio, Inc. PRPO | Bionano Genomics, Inc. BNGO |
|---|---|---|---|---|
| Year ended | 2026-06-30 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $913.0K | $16.58M | $24.05M | $28.51M |
| Revenue growth (YoY) | -13.0% | +17.0% | +29.8% | -7.4% |
| Gross margin | 23.8% | 51.1% | 44.5% | 46.3% (computed) |
| Operating margin | n/m | -470.5% | -5.0% | -116.9% |
| Net margin | n/m | -444.0% | -1.5% | -92.6% |
| Net income | -$14.43M | -$73.60M | -$363.0K | -$26.39M |
| EPS (Diluted) | n/a | n/a | -$0.23 | -$4.85 |
| Operating cash flow | -$13.45M | -$44.45M | $685.0K | -$16.34M |
| Free cash flow | -$14.33M | -$46.24M | $359.0K | n/a |
| Cash & equivalents | $8.39M | $47.28M | $2.65M | $2.99M |
| Total assets | $20.51M | $296.08M | $21.32M | $73.58M |
| Total liabilities | $4.33M | $36.78M | $6.76M | $29.16M |
| Shareholders' equity | $16.17M | $259.31M | $14.56M | $44.42M |
| Return on year-end equity | -89.2% | -28.4% | -2.5% | -59.4% |
| Shares outstanding | 2.00M | n/a | 1.78M | 10.74M |
Revenue, most recent five fiscal years
| Fiscal year | Astrotech Corp | Seer, Inc. | Precipio, Inc. | Bionano Genomics, Inc. |
|---|---|---|---|---|
| Latest | $913.0K Ended 2026-06-30 | $16.58M Ended 2025-12-31 | $24.05M Ended 2025-12-31 | $28.51M Ended 2025-12-31 |
| 1 year earlier | $1.05M Ended 2025-06-30 | $14.17M Ended 2024-12-31 | $18.53M Ended 2024-12-31 | $30.78M Ended 2024-12-31 |
| 2 years earlier | $1.66M Ended 2024-06-30 | $16.66M Ended 2023-12-31 | $15.20M Ended 2023-12-31 | $36.12M Ended 2023-12-31 |
| 3 years earlier | $750.0K Ended 2023-06-30 | $15.49M Ended 2022-12-31 | $9.41M Ended 2022-12-31 | $27.80M Ended 2022-12-31 |
| 4 years earlier | $869.0K Ended 2022-06-30 | $6.62M Ended 2021-12-31 | $8.85M Ended 2021-12-31 | $17.98M Ended 2021-12-31 |